FDA approves anti-psychotic, clozapine, to treat suicide

FDA approves anti-psychotic, clozapine, to treat suicide December 20, 2002 The first of the so-called atypical antipsychotic drugs, clozapine (Clozaril), has been approved by the FDA as a treatment against suicide in patients with schizophrenia. The drug has been hailed as a miracle for some, but deadly for others. The…

Investigative series finds kids drugged without cause – Journal News

November 08, 2002 Investigative series finds kids drugged without cause – Journal News The Journal News, a regional NYS newspaper conducted a three month investigation of residential treatment centers (RTC) for troubled children in NYS. The findings reported in a 7-part investigative series show “a pattern of increasing use” of…

Documents Show Drug Company Promotion of Unproven Drug – NYT

Documents Show Drug Company Promotion of Unproven Drug_NYT Tue, 29 Oct 2002 Internal company documents unsealed in a federal lawsuit reveal how the unholy alliance between doctors and drug companies has corrupted medical practice and defrauded the US taxpayer. Although it is illegal for drug companies to promote a drug…

Conflicts of Interest in Clinical Trials

Presented by Vera Hassner Sharav
14th Tri-Service Clinical Investigation Symposium
Sponsored by The U.S. Army Medical Department and The Henry M. Jackson Foundation for the Advancment of Military Medicine

The cornerstone of public trust in medical research is the integrity of academic institutions and the expectation that universities, which rely on public funding, have a responsibility to serve the public good. Financial conflicts of interest affect millions of American people – those who are subjects of clinical trials testing new drugs and those who are prescribed drugs after their approval.

Sharav Presentation before US Army Medical Dept., May 6, 2002

CONFLICTS OF INTEREST Presented by Vera Hassner Sharav 14th TRI-SERVICE CLINICAL INVESTIGATION SYMPOSIUM Sponsored By THE U.S. ARMY MEDICAL DEPARTMENT And THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCMENT OF MILITARY MEDICINE May 5-7, 2002 The cornerstone of public trust in medical research is the integrity of academic institutions and…

Protecting Human Subjects in Research: Are Current Safeguards Adequate?

Current federal regulations set no limits on the level of risk that a competent adult may voluntarily choose to undertake for the sake of science. The regulations require prior approval by a review board (IRB) to ensure the research meets scientific and ethical justification, to ensure that the risks and benefits (if any) are fully disclosed to the subject, and that the subject can exercise the right to give or withhold informed consent.

InfoMail for March 14, 2002

  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav March 14, 2002 Whistle-Blower SaysMarketers Broke the Rules to Push a Drug (Neurontin) FYI The New York Times reports that court papers in a civillawsuit "may provide a…

InfoMail for February 22, 2002

  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 22, 2002  Alzheimer’s Drug Tests Halted When 12Volunteers Contract Encephalitis FYI The culture that led to the death of 19-year old, NicoleWan, a University of Rochester…

InfoMail for February 20, 2002

  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 20, 2002  FYI How the Mental Health System hasImpeded Road to Recovery by Stripping Patients of their Humanity For those interested in gaining insight into the…